Attention Biotech Investors: Mark Your Calendar For September PDUFA Dates
August proved to be a mixed month for regulatory approvals, with the Food and Drug Administration approving a few, turning down a few others and delaying the remaining.
The Daily Biotech Pulse: MorphoSys-Incyte Snag European Nod, Immutep Granted Chinese Patent, Bolt Biotherapeutics Strike Oncology Collaboration
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs Aug. 26)
Incyte – MorphoSys’s Diffuse Large B-Cell Lymphoma Drug Wins European Approval
The European Commission (EC) has granted conditional approval to Incyte Corporation (NASDAQ:INCY) – MorphoSys AG’s (NASDAQ:MOR) Minjuvi (tafasitamab) for relapsed or refractory diffuse large…
MorphoSys And Incyte Announce European Commission Approval Of Minjuvi In Combination With Lenalidomide For Treatment Of Adults With Relapsed Or Refractory Diffuse Large B-Cell Lymphoma
MorphoSys AG ((FSE:MOR, NASDAQ:MOR) and Incyte (INCY) today announced that the European Commission (EC) has granted conditional marketing authorization for Minjuvi® (tafasitamab) in combination with lenalidomide,
Incyte Announces Health Canada Approval Of Minjuvi (tafasitamab) In Combination With Lenalidomide For Treatment Of Adults With Relapsed Or Refractory Diffuse Large B-Cell Lymphoma
Incyte (NASDAQ:INCY) today announced that Health Canada has granted a Notice of Compliance with conditions for Minjuvi® (tafasitamab), a humanized Fc-modified cytolytic CD19 targeting monoclonal antibody, in
BriaCell, ImaginAb Join Forces To Assess Imaging Tech In Breast Cancer Trial
BriaCell Therapeutics Corp (NASDAQ:BCTX) has announced a multi-year, non-exclusive license agreement with ImaginAb Inc for developing next-generation immuno-oncology imaging agents and radiopharmaceutical therapies.…
The Daily Biotech Pulse: Lilly Reorganizes Business Units In Neuroscience Focus, Helius Medical Spikes On Breakthrough Designation, Ra Medical Sells Dermatology Business
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs Aug. 16)
Incyte Out Licenses Lymphoma Drug To InnoCare In Greater China
Incyte Corporation (NASDAQ:INCY) and InnoCare have entered into a collaboration and license agreement to develop and commercial tafasitamab in Greater China. Under the…
BriaCell Therapeutics Attacks Cancer with Novel Off-the-Shelf Immunotherapies
Photo by Chokniti Khongchum from Pexels
The Daily Biotech Pulse: Moderna’s Vaccine Produces Durable Response Against Variants, FDA Approves Jazz’s Sleep Disorder Drug, Dermata IPO
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs Aug. 12)